Abstract
Since the U.S. Food and Drug Administration (FDA) statement on mesh in July of 2011, there has been controversy regarding synthetic mesh repairs for vaginal prolapse. In this article, we review the biochemical basis for the use of synthetic mesh in prolapse repair as well as clinical results of anterior compartment prolapse repair with synthetic mesh. Finally, we discuss the FDAwarning regarding mesh.
Original language | English (US) |
---|---|
Pages (from-to) | 211-215 |
Number of pages | 5 |
Journal | Current Urology Reports |
Volume | 13 |
Issue number | 3 |
DOIs | |
State | Published - Jun 2012 |
Keywords
- FDA
- Female urology
- Pelvic organ prolapse
- Vaginal mesh
- Women's health
ASJC Scopus subject areas
- Urology